€2.7 MILLION RAISED – MARKET CAPITALISATION OF €18.7 MILLION
Paris –19 December 2014 – EnterNext, the Euronext subsidiary designed to promote and grow the market for SMEs[1], today congratulated orthopedic implant I.CERAM on its listing on Alternext in Paris (ticker code: ALICR).
Founded in 2006 in Limoges, France, I.CERAM designs, produces and sells both orthopedic implants recognised internationally for their innovative features and ceramic implants offering unique biocompatibility. The company already has 14 products on the market, protected by 11 international patents. It operates its own ceramics lab where its research team that has developed a revolutionary surgical solution—the first active bone implant. I.CERAM also draws on cutting-edge production facilities and its management’s 30-plus years’ experience.
I.CERAM was listed through the admission to trading of the 4,030,645 shares making up its equity, as well as 588,180 new shares issued in a private placement.
The admission and issue price of I.CERAM shares was set at €4.65 per share. Market capitalisation was around €18.7 million on the day of listing, and the transaction raised a total of over €2.7 million.
“I want to congratulate I.CERAM on its successful listing on Alternext,” said Eric Forest, Chairman and CEO of EnterNext. “I.CERAM is an innovative company whose accomplishments have won over investors. We at EnterNext are delighted to support the company as it enters the market, helping raise the capital it needs to expand.”
André Kerisit, Chairman of I.CERAMadded: “We are very pleased with our listing, which marks a key stage in our company’s development. I.CERAM’s market debut will help us leverage our unique know-how in bioceramic implants and deliver an effective solution to the treatment of bone infections. I would like to thank all of the investors who have taken part and demonstrated their trust in this first transaction.”
[1] Small and medium-size entreprises